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The structural basis for the genetic and antigenic variation in influenza viruses has 
been extensively studied in the past  to elucidate the mechanisms and requirements 
for  the  emergence of antigenically  novel  strains  (1-4).  In  particular,  monoclonal 
antibodies have been widely used to study the frequencies of antigenic variants (5-7) 
and  to  map  the  amino  acid  changes  in  the  antigenically relevant  portions of the 
hemagglutinin  (HA) 1 molecules of natural  and  laboratory-obtained variants  (8, 9). 
With  the availability of primary sequence information for several different strains 
within the H3N2 subtype, Wiley et al. (10) have identified four antigenic sites on the 
three-dimensional structure of I--Iong Kong virus HA molecules using x-ray crystallog- 
raphy. 
In contrast to the impressive advances that have been made in the understanding 
of structure  and  variation  of influenza  virus  HA,  only limited  data  are  available 
related to clonal expression during anti-HA responses. Cancro et al.  (11)  compared 
the reactivity pattern of monoclonal anti-HA antibody populations in  12-14-d-old 
and adult mice, and obtained preliminary results indicating that there were relatively 
few responding clonotypes in young animals as compared with adult animals. 
The aim of the present study was to investigate the clonal basis of immune responses 
to influenza viral HA by studying the idiotypy of monoclonal antibodies and anti- 
HA antibodies synthesized in response to immunization with influenza virus. Idiotypes 
have been  widely used  as  tools to  study clonal  responses to  a  variety of antigens, 
taking advantage of the fact that idiotypes are phenotypic markers of V  region genes 
(12). Our results showed that monoclonal antibodies specific to different determinants 
of PR8 HA share idiotypes and that  monoclonal antibodies specific to the same or 
overlapping  determinants  of  B/Lee  HA  also  share  idiotypes.  The  cross-reactive 
idiotypes of monoclonal antibodies are shared with anti-HA antibodies synthesized in 
response to a  conventional immunization with  intact  B/Lee virus.  Variations  and 
persistence of the cross-reactive idiotypes were observed during conventional primary 
and secondary anti-HA antibody responses. 
Materials and Methods 
Mice.  BALB/c mice were obtained from Charles River Breeding Laboratories, Inc.  (Wil- 
mington, Mass.) and were used between 5 and  15 wk of age. 
* Supported  by  research grants AI  14053, A!  109304,  and AI  18316  from  the U.S.  Public  Health 
Service. 
1Abbreviations  used  in  this paper:  FCS,  fetal  calf serum;  HA,  hemagglutinin;  HI,  hemagglutination 
inhibition; IdI, individual idiotype; IdX, cross-reactive idiotype; RDE, receptor-destroying enzyme; RIA, 
radioimmunoassay; SRBC, sheep erythrocytes; SRIA, solid-phase radioimmunoassay. 
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Monoclonal Antibodies.  Monoclonal antibodies against HA of influenza viruses A/PR/8/34 
(HON1) (PR8 virus) and B/Lee/40 (B/Lee virus) raised by M. D. Lubeck et al. (6) were used. 
Viral Antigens.  Influenza PR8 virus and B/Lee virus were obtained from laboratory stocks 
and grown in the allantoic cavity of 10-11-d-embryonated chicken eggs and were purified by 
standard procedures (13). 
Selection of Antigenic Variants.  Antigenic variants were selected  on MDCK cell monolayers 
using cloned virus seeds in the presence of excess monoelonal antibodies (6) to ensure that all 
nonneutralized virus plaques were produced by variants. Each plaque was picked separately 
and was confirmed to be a variant by antiviral hemagglutination inhibition (HI) test and/or 
the absence of neutralization with the same monoclonal antibody used in selection. Seed stocks 
of the variants were prepared by inoculation of 10-11-d-embryonated chicken eggs (13). 
Determination of Subclasses.  Subclasses  of monoclonal antibodies were determined by solid- 
phase radioimmunoassay (SRIA) (14). Briefly, microtiter wells were coated with 50 #1 of 50 #g/ 
ml of affinity-purified monoclonal antibodies overnight. After three washings with saline, they 
were  incubated for  1 h with 50% fetal calf serum (FCS), and then with different 3H-labeled 
goat  antimurine IgM or IgG classes  for  3 h.  After extensive washing, the radioactivity was 
counted in a  scintillation counter. The 3H-labeled goat antimurine Ig antibodies were  a  gift 
from  P.  Mongini (Laboratory of Immunology, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health). 
Preparation ofAnti-idiotype Antisera.  Syngeneie anti-idiotype (auti-Id) antisera against mono- 
clonal antibodies Bl18,  B142,  and  B147  (specific  for  B/Lee  HA),  and homologous anti-Id 
antiserum against monoclonal antibody P28 (specific for PR8 HA) were prepared in BALB/c 
and A/J mice, respectively, according to a previously described technique (15). The homologous 
anti-Id antiserum was extensively adsorbed on a Sepharose 4B-BALB/c Ig column to eliminate 
antiallotype antibodies before use.  (Initial efforts  to raise syngeneic anti-P28 antiserum were 
unsuccessful.) 
Immunization and Bleeding.  24 mice were divided into two groups. In the primary immune 
response group, mice were immunized with 5 #g of purified B/Lee virus and bled 5, 10, 20, 30, 
and 60 d after immunization. In the secondary immune response group, mice primed with 5 
#g of purified B/Lee virus were boosted 1 mo later with the same amount of B/Lee virus, and 
then bled 3, 7, 10, 20, and 30 d after boost. Antiviral HA titers of antisera pooled from pairs of 
mice in the group of 12 mice were measured in antiviral HI assays, and were reported as means 
±SD. The expression of cross-reactive idiotypes was studied by HI assays and radioimmunoassay 
(RIA). 
Antiviral HI Assays.  Sera or ascites  fluids were assayed in a standard antiviral HI test after 
treatment with receptor-destroying enzyme (RDE, World Health Organization, Atlanta, Ga.; 
16). The HI titers were reported as log2 of the reciprocal of the highest dilutions  of RDE-treated 
samples that inhibited hemagglutination. 
Assays for Idiotypes.  The assays for cross-reactive  idiotypes involved HI and RIA, and were 
performed as follows. (a) HI assay (15): sheep erythrocytes (SRBC)  were coated with 1 mg/ml 
purified monoclonal antibodies using the chromic chloride method (17). The capacity of other 
monoclonal antibodies or antiviral sera to inhibit agglutination of these coated erythrocytes by 
the corresponding or noneorresponding anti-Id antibody was determined. The HI titers were 
reported as log2 of the reciprocal of the highest dilution of inhibitors (original concentration 
=  1 mg/ml) that inhibited  hemagglutination. (b) RIA (18): both direct binding  and competition 
inhibition assays were used to study cross-reactive  idiotopy. Microtiter wells were coated with 
affinity-purified anti-Id sera by overnight incubation followed  by three washings with saline. 
They were then incubated with 50% FCS for  1 h and washed three times. In direct binding 
assays,  plates were incubated with ~2SI-labeled monoclonal antibodies for 3 h. After extensive 
washing, the  radioactivity was  counted in the  y-spectrophotometer.  In competition assays, 
measurements were made of the capacity of other monoclonal antibodies to inhibit binding of 
~2~I-labeled monoclonal antibody to anti-Id antibody-coated microtiter plates. 
Viral Inhibition Assay.  To determine the ability of purified virus to inhibit the binding of 
monoclonal antibodies with anti-Id antibodies, mixtures of 125I-labeled monoclonal antibodies 
and various concentrations of purified virus were preincubated for 1 h and then added to plates 
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Iodination of Monoclonal Antibodies.  Affinity-purified  monoclonal  antibodies  were  iodinated 
according to chloramine T  method described by Greenwood et al.  (19). The specific activities 
were ~  15/~Ci//tg protein. The labeled monoclonal antibodies' were stored at -20°C  in aliquots 
and used within 6  wk of iodination. 
Results 
Characterization of Monoclonal Antibodies to  PR8  Virus in  Terms of Antiviral  HI  Titers, 
Subclasses, and Fine Specificities.  The monoclonal antibodies to PR8 virus HA used in 
these studies were P8, P20, and P28. Their antiviral HI titers and subclasses are listed 
in  Table I. All  three  monoclonal  antibodies  have similar antiviral  HI activity.  P8, 
P20, and P28 belong to subclasses IgG2b,  IgG2b, and IgG1, respectively. 
These monoclonal antibodies were determined to be specific for distinct  antigenic 
determinants on PR8 HA on the basis of the following criteria. (a) The frequencies of 
antigenic variants in the presence of pairs of monoclonal antibodies were equivalent 
to the products of those observed in the presence of each monoclonal antibody alone 
(5)  (data  not  shown).  (b)  When  variants  selected  in  the  presence  of a  particular 
TABLE  I 
Summary of Antiviral HI Titers and Subclasses of Monoclonal Antibodies 
Monoclonal  Antigen recognized  HI titers (logs  Subclasses 
antibodies  units)* 
P8  PR8 (HA)  7  IgG2b 
P20  PR8 (HA)  8  IgG2b 
P28  PR8 (HA)  8  IgG1 
B 109  B/Lee (HA)  7  lgG1 
B118  B/Lee (HA)  8  lgGl 
B 123  B/Lee (HA)  9  IgG1 
B 127  B/Lee (HA)  8  IgGl 
B 141  B/Lee (HA)  8  IgG1 
B 142  B/Lee (HA)  7  [gG2a 
B147  B/Lee (HA)  9  ND~: 
* Twofold dilutions of RDE-treated ascites were used to inhibit the hemagglu- 
tination of human erythrocytes by 32 hemagglutinating units of either PR8 
or B/Lee virus. The titers are expressed as the reciprocal (log2) of the highest 
dilution that causes inhibition of hemagglutination. 
:~ Not determined. 
TABLE  II 
Reactivity of Monoclonal Antibodies to PR8 Virus HA with  Variants Selected 
with Different Monoclonal Antibodies 
Viruses 
Number of 
variants 
examined 
Range of HI titers (logs units)* 
P8  P20  P28 
PR8  --  7  8  8 
P8 variants~  8  <1  6 ~  7§  6 ~  8 
P20 variants:~  7  5 ~  7  <1  6 ~  8 
P28 variants~:  6  5 ~  7  6 -  7  ___1 
* Same as Table I, except PR8 viruses or variants were used. 
:~ P8, P20, and P28 variants were variants of PR8 virus selected in the presence 
of excess P8, P20, and P28 monoclonal antibodies, respectively. 
§ Range  of HI  titers  of each  monoclonal  antibody  with  different  variants 
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monoclonal  antibody  were  examined  in  HI  or  neutralization  assays,  monoclonal 
antibodies directed to other determinants still  reacted at relatively unchanged titer. 
The HI titers of P8, P20, and P28 to PR8 virus and variants are shown in Table II. 
It can be seen that variants selected in the presence of P8 (P8 variants), in the presence 
of P20 (P20 variants), or in the presence of P28 (P28 variants) did not react with the 
monoclonal antibodies used in selection. However, the titers of monoclonal antibodies 
not used in the selection remained relatively unchanged. For instance, P8 no longer 
reacted with P8 variants but P20 and P28 still  reacted with P8 variants at high titers. 
Thus, it is evident that PS, P20, and P28 are reactive with different determinants on 
the PR8 HA molecule. 
Characterization  of Monoclonal  Antibodies  to  B/Lee  Virus  HA:  HI  Titers,  Subclasses,  and 
Fine Specificities.  The  HI titers and subclasses of the monoclonal  antibodies to B/Lee 
HA  are  also  listed  in  Table  I.  Again,  these  monoclonal  antibodies  have  similar  HI 
titers,  and  B109,  BlI8,  B123,  B127,  and  B141  belong  to  subclass  IgG1,  but  B142 
belongs to subclass IgGza. 
These  monoclonal  antibodies  were  determined  to be directed  against  the same  or 
overlapping  epitopes  partially  on  the  basis of HI  results  shown  in  Table  III.  In  all 
cases,  monoclonal  antibodies  used  to  select  variants  either  did  not  react  with  those 
variants or reacted  at  significantly lower titer than  with wild-type  virus. In addition 
(Table III), monoclonal  antibodies other than  those used to select a  particular  group 
of variants did not react or reacted at significantly lower titer with at least some of the 
variants  in  that  group  than  with  wild-type  virus.  For  example,  all  monoclonal 
antibodies tested reacted at lower titer with all six variants selected in the presence of 
B118  than  with  wild-type  virus.  Similar  results were  obtained  in  HI  assays  with  at 
least  some  of  the  variants  selected  with  other  individual  monoclonal  antibodies. 
Although  other  monoclonal  antibodies  reacted  with the two  variants selected  in the 
presence of B147 at  relatively high titer, B147  reacted at reduced  titer with all but  a 
few of the variants selected  in the presence of other monoclonal  antibodies, strongly 
suggesting that  B147  is directed  at a  determinant  that  overlaps with that  recognized 
TABLE  III 
Reactivity of Monoclonal Antibodies to B/Lee Virus HA with  Variants Selected with 
Different Monoclonal Antibodies 
Viruses 
Number 
of variants 
examined 
Range of HI titers (logs units)* 
BI09  B127  B142  B141  B123  Bll8  B147 
B/Lee 
B 109 variants~ 
B127 variants 
B 142 variants 
B141 variants 
B123 variants 
B118 variants 
B147 variants 
--  7  8  7  8  9  8  9 
6  <1  <1  ~l  4 ~  9§  4 ~  7  5-  8  1 n  9 
6  <1  <1  <1  <1  ~  5  5  <1~  7  <1  ~  6 
4  <1  <1  <1  <1-9  4~9  <1  ~  7  2~6 
6  <1  <1  <1  2~6  5~  7  3~6  <1  ~8 
2  <1  <1  ~4  <1  4~6  <1  ~3  4  <1 
6  <1 ~4  <1 ~6  4~6  <1~6  4-6  <1  ~4  <1 
2  6~  7  5~6  6~  7  7~8  5~6  5 ~6  <1 
* Same as Table I, except that either B/Lee virus or variants were used. 
:~ B109, B127, B142, BI41, B123, B118,  and B147 variants were variants of B/Lee viruses selected in the 
presence of excess B109, B127, B142, BI41, B123, B118, and B147 monoclonal antibodies, respectively. 
§ Range of HI  titers of each monoclonal antibody with different variants selected in the presence of a 
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TABLE IV 
Reactivity of Monoclonal Antibodies to PR8 Virus HA with A/J Anti-P28 
Antiserum Assayed by HI and RIA 
Competition  RIA (purified 
Monoclonal antibodies  HI titers (log2)*  antibodies giving 50% 
inhibition)¢ 
ttg/ml 
P8  6  <0.01 
P20  > 12  <0.01 
P28  6  <0.01 
B109  0  >100 
* Dilution of purified monoclonal antibodies (original concentration  1 mg/ml) 
that inhibits the binding of A/J anti-P28 antibody to SRBC-P28. 
~: Concentration  of purified monoclonal antibody that causes 50% reduction of 
binding of 125I-labeled P28 (50,000 cpm of ~10  n cpm/#g) to 20 pg/ml anti- 
P28-coated wells. 
TABLE V 
Inhibition by PR8 Virus of Binding of Monoclonal Antibodies against PR8 
HA to Anti-P281d Antibody 
Purified PR8 virus giving 50%  125I-labeled  monoclonal antibodies  inhibition* 
#g/ml 
P8  0.9 
P20  0.8 
P28  0.4 
* Concentration  of purified PR8 virus that causes a 50% reduction of binding 
of 125I-labeled monoclonal  antibodies  (50,000 cpm of 105 cpm/#g)  to 40 
p.g/ml anti-P28Id  antibody-coated wells. 
by the other antibodies. In addition, when these variants were tested in neutralization 
assay  with  the  monoclonal  antibodies  listed  in  Table  III,  reduced  reactivity  was 
observed in all instances (data not shown). Finally, the frequency of antigenic variants 
detected in cloned  virus seeds in  the presence of a  single monoclonal  antibody was 
equivalent  to  that  observed  when  any  two  monoclonal  antibodies were  combined 
(data not shown). 
Cross-reactive Idiotypy among Monoclonal Antibodies to PR8 Virus HA.  When homologous 
anti-P18  antiserum  was  used  to  detect  shared  idiotypes among  P8,  P20,  and  P28, 
extensive reactivity was demonstrated  (Table IV) in both HI assays and competition 
RIA. These results were somewhat surprising in view of the fact that we had previously 
demonstrated  that  these three monoclonal  antibodies are directed to  different anti- 
genic  determinants.  In  contrast,  no  cross-reactivity with  monoclonal  antibodies  to 
B/Lee  HA  was  observed.  Similarly, in  assays of direct  binding of 12~I-labeling P8, 
P28, and B109  (50,000 cpm of ~  106 cpm/pg) to anti-P28 antibody (20/.tg/ml)-coated 
plates, the results obtained were  1,376, 9,893,  and 220 cpm, respectively. 
In the further study of reactivity of monoclonal antibodies to PR8  HA, we found 
that binding of anti-P28 to monoclonal antibodies against PR8 HA was inhibited by 
purified PR8 viral antigen (Table V). These results indicate that anti-P28 recognizes 
determinants on monoclonal antibodies closely associated with their antigen-binding 
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TAnLE  VI 
IdI Expressed on Different Monoclonal Antibodies to B/Lee HA Detected by 
HI Assays and RIA 
Inhibitors 
Anti-B118  Anti-B147  Anti-B142 + B142  + Bl18  + B147 
HI*  RIA~  HI  HI 
B109  8  5  ND§  ND 
B118  0  >100  8  0 
B123  0  >100  ND  ND 
B127  0  >100  ND  ND 
B141  0  100  ND  ND 
B142  7  1  2  0 
B147  ND  >100  3  3 
P8  0  >100  0  0 
* Dilution of purified monoclonal antibodies (original concentration  1 mg/ml) 
that  inhibits  the  binding of anti-Id antibodies  to  SRBC  coupled  with 
monoclonal antibodies against B/Lee HA. 
~: Concentration of purified monoclonal antibody that causes 50% reduction of 
binding of 125I-labeled B142 (50,000 cpm of ~ l0  s cpm//Lg) to 3/~g/ml anti- 
B 142-coated wells. 
§ Not determined. 
Cross-reactive Idiotypy among Monoclonal Antibodies to B/Lee  Virus HA.  The presence of 
individual idiotypes (IdI) and cross-reactive idiotypes (IdX)  on  B/Lee-specific mon- 
oclonal antibodies was  studied using syngeneic anti-Id antisera  (i.e.,  BALB/c  anti- 
Bl18,  anti-B142,  and  anti-B147).  The  IdI was  studied in  three systems  (Table VI). 
(a) Anti-B142Id antibodies vs. B142.  In this system, we found that only B109 shared 
the idiotypic determinants of B 142 detected in both HI assays and inhibition RIA. In 
addition,  when  direct  SRIA  (data  not  shown)  were  done  with  125I-labeled B/Lee- 
specific monoclonal antibodies (50,000  cpm of ~  106 cpm//~g)  and  anti-B142Id anti- 
body  (3/~g/ml),  >3,000  cpm  of 12SI-B142  and  125I-B109  were  bound  to  the  plates, 
whereas <400 cpm of other radiolabeled monoclonal antibodies were bound. (b) Anti- 
B118Id antibodies vs. B118.  In this system we found that B142  and B147  share some 
idiotypic determinants of B118  as assessed by HI assays;  (c)  Anti-B 147Id antibodies 
vs.  B147.  No other monoclonal  antibodies studied expressed the IdI of B147.  These 
results  suggest  that  some  monoclonal  antibodies  (e.g.,  B147)  may  bear  a  true  IdI, 
whereas some individual idiotopes (e.g., idiotypes detected by anti-B 142Id antiserum) 
can be shared by only few monoclonal antibodies. 
To study IdX, an HI assay that allowed the investigation of shared idiotypes (IdX) 
and  minimized the role of IdI was used. This technique was used previously (20)  in 
studies of the IdX of a  human  IgM myeloma with rheumatoid activity in which IdX 
were  initially discovered  and  thereafter  in  the  study  of IdX  of murine  myeloma 
proteins (21). 
The  IdX  of  monoclonal  antibodies  were  studied  by  HI  in  three  systems.  (a) 
Inhibition of binding of 12~I-labeled anti-B 118Id and ant i-B 142Id antibodies to SRBC- 
B 109: as shown in Table VII, in both systems all monoclonal antibodies expressed the 
IdX  (i.e., inhibited binding).  (b)  Inhibition  of binding of radiolabeled anti-B147Id 
antibodies  to  SRBC-B109:  in  this  system  only  three  of six  monoclonal  antibodies YUNG-NAN LIU, CONSTANTIN  BONA, AND JEROME  SCHULMAN 
TABLE VII 
IdX Expressed on Different Monoclonal Antibodies to B/Lee HA Detected by 
HI Assays 
Inhibitors 
HI titers (logz) anti-Id antiserum + ligand* 
Anti-B118 +  Anti-B142  +  Anti-B147  + 
SRBC-B109  SRBC-B109  SRBC-B109 
B109  4  5  6 
Bl18  5  3  0 
B123  5  3  0 
B127  4  3  0 
B141  4  4  4 
B142  4  5  6 
P8  0  0  0 
* Dilution of purified monoclonal antibodies (original concentration 1 mg/ml) 
that  inhibits the binding of various anti-Id antisera to SRBC coated with 
B 109 monoclonal antibody. 
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TABLE  VIII 
Inhibition by B/Lee Virus of Binding of Monoclonal Antibodies to 
Anti-Id Antibodies 
125I-labeled monoclonal 
antibodies 
Purified B/Lee virus  giving 50% inhibition* 
Anti-B  118  Anti-B  142 
pg/ml 
B 109  ND~:  0.7 
B  118  0.6  0.9 
Bl42  0.9  1.0 
* Concentration of purified B/Lee virus that causes a 50% reduction of binding 
of 12~l-labeled  monoclonal antibodies (50,000 cpm of ~10  s cpm/~g) to  10 
pg/ml anti-B118 or anti-B142 antibody-coated wells. 
:~ Not determined. 
expressed the IdX. These results indicate that some of the monoclonal antibodies bear 
a  true IdI, some express idiotypes shared by few members, and some bear a  true IdX. 
The  binding of syngeneic anti-Id antibodies to  monoclonal antibodies to  B/Lee 
HA was inhibited by purified B/Lee viral antigen (Table VIII). These results indicate 
that  anti-Id antibody recognizes antigenic determinants on  monoclonal antibodies 
closely associated with their antigen binding sites. 
Idiotypes Expressed during the Primary and Secondary Antiviral Response of Mice Immunized 
with B/Lee Virus.  When primary and secondary immune sera from mice immunized 
with  B/Lee  virus were  tested  for  their  antiviral HI  activity,  typical  primary  and 
secondary responses were observed (Fig.  1).  During the primary immune response, a 
lag period of -5  d  was followed by increasing antiviral antibody titers that reached 
a  peak  10-20 d  after immunization and then slowly declined. During the secondary 
immune response, antibody titers increased after a  very brief lag phase  (<3 d)  and 
reached a  plateau by day 7 after booster immunization. 
The same immune sera were used in four systems in HI assay to study idiotypic 
expression during primary and secondary immune responses. As illustrated in Fig. 2, 
the  titer  of  IdX  detected  by  anti-Bll8  and  SRBC-B123  was  2.3  +  0.5  before 1532  IDIOTYPY OF  ANTIHEMAGGLUTININ ANTIBODY 
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immunization,  reached  a  peak of 4.2  +  0.9  on  day 5  during  the  primary immune 
response, and dropped gradually thereafter. Following secondary immunization, there 
was  an  initial  decline  in  the  titers  of this  idiotype  (possibly  due  to  formation  of 
complexes between  idiotype  and  viral  antigen).  Thereafter,  titers  rose  slowly  and 
reached a peak of 4.7 +  0.5 on day 20 after secondary immunization. 
The  titer  of IdX  detected  by  anti-Bll8  and  SRBC-B142  was  1.2  +  0.7  before 
immunization.  During the primary immune response, it reached a  plateau of 3.0  + 
0.6  on  day  5,  and  began  to  decline  on  day  20  after  immunization.  During  the 
secondary immune response, the same idiotype, after an initial  decline period,  rose 
rapidly in titer,  reaching a  lower peak than  was seen in the primary response, and 
declined slowly thereafter. 
The HI titer of IdX detected by anti-B142  and SRBC-B109 was  1.8  +  0.8 before 
immunization.  After primary immunization, it rose immediately, reached a  peak of 
-4.0 between  days 5 and  10,  and then declined.  In contrast  to the other idiotypes, 
this idiotype did not increase significantly in titer during the first 30 d of the secondary 
immune response. 
The  HI  titer  of IdX  detected  by  anti-B147  and  SRBC-B109  was  3.5  +  0.5  in 
nonimmunized animals. A slight decrease during the primary immune response was 
observed. However, the titer of the same idiotype increased promptly after secondary 
immunization and then decreased gradually. 
To determine whether or not  the  IdX expressed early in  the  secondary response 
was attributable to antibody molecules with anti-HA specificity, we pooled the sera 
obtained 3 and 7 d after secondary stimulation and passed the pool through a B/Lee- 
Sepharose affinity column to separate the fractions that bound and did not bind to 
B/Lee virus. The two fractions then were tested in a conventional antiviral HI assay, 
and for IdX expression in HI assay using the anti-B147 and SRBC-BI09 system. All 
antiviral activity was recovered in the fraction that bound to virus, but this fraction 
contained  only  11%  of the  HI activity in  the  anti-B147  SRBC-B109  system.  Con- 
versely, the unbound fraction lacking detectable antiviral HI activity was responsible 
for 89% of the IdX expression. These results suggested that the majority of the IdX 
detected in the secondary response was due either to a  parallel Aba or to Ab3.  In an 
effort to distinguish  between these two possibilities, we searched  for the presence of 
Ab2 (which could have provided the stimulus for Aba synthesis)  in sera obtained 20 
and  30  d  after  primary  immunization.  Using  direct  hemagglutination  assay  with 
SRBC coated with B109, we were unable to detect anti-Id (i.e., Ab2) antibodies in the 
late period of the primary immune response when IdX titers were declining. 
Discussion 
Although  the  structural  basis  for  antigenic  variation  of influenza  A  virus  HA 
molecules has been elucidated  by recent  sequence  analysis of variants  (8,  9),  as yet 
little is known about the clonal nature of the anti-HA responses that confer immunity 
to infection. The availability of monoclonal antibodies to influenza virus HA and of 
techniques  for  raising  anti-Id  antibodies  provide  a  potentially  powerful  tool  for 
investigation  of the  idiotypes expressed during the immune response and  for deter- 
mining whether specific antibodies to antigenic variants are derived from a diverse set 
of clonotypes or from the progeny of common ancestor clones. In the present studies, 
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selected in the presence of other monoclonal antibodies and detected frequencies of 
antigenic variants in the presence of pairs of monoclonal antibodies, P8, P20, and P28 
were  determined  to  be  directed  to  different  determinants  on  the  PR8  virus  HA, 
whereas  the  seven  monoclonal  antibodies  to  B/Lee virus were  found  to recognize 
overlapping determinants on the B/Lee virus HA (Tables II and III). 
Analysis of the idiotypy of the three PR8 HA-specific monoclonal antibodies with 
homologous  anti-Id  antisera  revealed  extensive  cross-reactivity, as  assessed  in  HI 
assays and  RIA  (Table IV).  This unusual  idiotypic cross-reactivity has been found 
previously in other systems among antibodies to different determinants on the same 
molecule (22,  23),  antibodies to different antigen  molecules (24), and  antibodies of 
unknown specificities (24,  25).  The finding of shared IdX among P8, P20, and P28 
monoclonal antibodies despite both their different antigenic specificities and the fact 
that they are of different IgG subclasses suggests that the IdX is encoded by a germ- 
line gene(s). 
With  respect  to  the  mechanism  responsible  for shared  IdX  among  monoclonal 
antibodies of different IgG subclasses specific for different HA determinants, several 
explanations can  be entertained.  (a)  The clones associated with  different antibody 
specificities but similar idiotype specifities are derived from one ancestral clone or V 
gene ancestor.  During  embryonic development and  clonal expansion after antigen 
stimulation, somatic mutations may occur in V region genes so that different antibody 
specificities are generated, whereas idiotype specificities remain relatively unchanged 
(26).  (b) The VH region of immunoglobulin is encoded by separated V  and J  genes. 
During  B  cell  maturation,  V  and J  regions  are juxtaposed,  so  it  is  possible  that 
antibodies bearing different antigen  binding specificities may have identical J  seg- 
ments  (26,  27).  (c)  During  B  cell maturation,  different minigenes  (D genes)  which 
code for  1-7  amino  acids  are  inserted  between V  and J  genes.  This  D  gene  may 
contribute to the distinct antigen-binding specificities, but antibodies may still have 
cross-reactive idiotypic determinants  (23,  28).  (d)  The IdX  represent(s)  regulatory 
idiotype(s) capable of becoming dominant idiotypes because it is these determinants 
that stimulate idiotype-specific regulatory cells (29). 
The  data  obtained  in  the  present  experiments  do  not  permit  us  to  distinguish 
among these possibilities. However, it should be noted that IdX were detected among 
PR8-specific and B/Lee-specific monoclonal antibodies, but no idiotypic cross-reac- 
tivity between the two groups of monoclonal antibodies was  detected. These latter 
results  suggest  that  the  finding of IdX  among  monoclonal  antibodies  to  different 
antigenic determinants on PR8 HA may reflect the effects of regulatory idiotopes (see 
d, above). 
The study of the idiotypes expressed by monoclonal antibodies specific for B/Lee 
HA (Tables VI and VIII) demonstrated that these monoclonal antibodies bear three 
categories  of idiotypic  determinants:  (a)  idiotopes  borne  by  a  single  monoclonal 
antibody, equivalent to an individual antigenic specificity of a myeloma protein (30), 
i.e., an IdI;  (b) idiotypic determinants shared by a few but not all of the monoclonal 
antibodies;  (c) IdX borne by monoclonal antibodies specific for the same or overlap- 
ping antigenic determinants on B/Lee HA. 
It should be emphasized that the B/Lee-specific monoclonal antibodies used are of 
different subclasses  (Table I). Moreover, although they are directed to overlapping 
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bind to B/Lee has been found to vary over a wide range, z Hence, the IdX observed 
among  these antibodies  is  not  attributable  to  their being products of a  particular 
clonotype. Nevertheless, the finding of IdX among antibody populations with over- 
lapping but  nonidentical specificities is not  unexpected and could be explained by 
any of the four mechanisms discussed above. 
In addition, it should be noted that with monoclonal antibodies to both PR8 and 
B/Lee binding to anti-Id antibody was inhibited by prior incubation of monoclonal 
antibodies with  virus  (Tables V  and  VIII).  These results  are  compatible with  the 
assumption that the idiotypic determinants are closely associated with the combining 
site.  However, this does not  mean  that  idiotypic determinants that  no longer react 
with  anti-Id  after interaction  with  virus  are  necessarily combining-site associated. 
Indeed,  Kunkel  et  al.  (31)  showed  that  binding  of anti-Rh  antibodies  to  a  large 
antigen such as erythrocytes can lead to the disappearance of some idiotypic deter- 
minants and the appearance of other antigenic determinants that are different from 
those associated with the combining site. 
Both persistence and variation of idiotypes during the immune response have been 
demonstrated in other systems. Thus, in humans it was shown that idiotypes of anti- 
Rh antibodies can persist for several years and in mice that the idiotype ofantigalactan 
antibodies can persist for 150 d (32-33). In contrast, it was shown in rabbits that some 
idiotypes of anti-Salmonella  typhi (34), anti-M, lysodeikticus (35), or antiphenylarsonate 
(36), detected early after immunization, disappear and are replaced by new idiotypes 
in the late phases of the immune response. In the hen lysozyme system of mice, the 
IdX hen lysozyme was found only in the secondary immune response (37). 
In general, the results we obtained from studies of the idiotypes expressed during 
immune responses of mice with B/Lee virus are in accord with these observations in 
that both persistence and variation of different idiotypes during primary and second- 
ary immunization were observed. It should be noted that  the IdI detected by anti- 
B147  and  SRBC-B147  was  not  observable  in  the  sera  of mice  after  primary  or 
secondary immunization with B/Lee virus. Some IdX were detectable in the sera of 
mice before immunization.  The presence of IdX  in  nonimmunized  mice could be 
explained either by antibodies with unknown specificities that could share the IdX of 
monoclonal antibodies or, alternatively, by the existence in the nonimmunized mice 
of a small amount of antibody to B/Lee HA, undetectable by antiviral HI assay but 
detectable by PFC assay (38). 
The IdX detected by anti-B118 and  SRBC-BI23, and  by anti-Bll8  and  SRBC- 
B 142, were expressed during both primary and secondary immune responses, indicat- 
ing that such clones dominate the anti-B/Lee HA responses in adult BALB/c mice. 
In contrast, the IdX detected by inhibition of binding of anti-B142 to SRBC-B109 
was observed only during the primary response. This absence of idiotype during the 
secondary response could be explained by (a)  the induction of an anti-Id antibody 
during the secondary response that clears the corresponding idiotype from the blood, 
or (b) the appearance of suppressor T cells specific for the idiotype that suppresses the 
expression of this idiotype. These hypotheses are under investigation. 
The level of idiotype detected by anti-B147 and SRBC-B109 was high in nonim- 
munized mice, but was reduced after primary immunization. On the other hand, this 
idiotype was expressed immediately after secondary stimulation.  The high titers of 
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this idiotype during the secondary response could be explained by one (or more) of 
the following mechanisms:  (a)  expression during the secondary response but not the 
primary response of an Abl (Id) having antigen specificity and bearing the IdX, (b) 
expression  of a  parallel  Abl  bearing  the  IdX  but  lacking  antigen  specificity,  (c) 
induction  of Ab3 (anti-anti-Id)  that bears the IdX and either does or does not  have 
antigen-binding specificity. Since the majority of IdX expressed early in the secondary 
response was found in the serum fraction that did not bind to virus, Abl and Abs with 
antigen  specificity may be excluded  as  major sources of the  IdX-bearing antibody 
seen in the secondary response. Although we could not detect anti-Id (Ab2) antibody 
in sera obtained late in the primary response, we cannot exclude the possibility that 
Ab2 antibody in concentrations too low to be detected with the assay system used, in 
the form of complexes, or sequestered in lymphoid organs, was present in quantities 
sufficient to induce an Ab3 response. Hence, we are unable at present to distinguish 
whether the preponderance of IdX observed in the secondary response using the anti- 
B147 SRBC-BI09 system is due to a parallel Abl set or to Abs. 
Based on this information on the variation ofidiotypes during the anti-HA response, 
which  reflects alterations  in  clonal  expression, we intend  to characterize  the clones 
relevant for host  defense mechanisms using either an idiotype suppression model or 
selective activation of clones by injection of minute amount of anti-Id antibodies at 
birth, which may lead to a  B clonal dominance, as has been shown in the anti-~2-6 
fructosan A48Id system (39). 
Summary 
Anti-idiotype  antisera  were raised  in  syngeneic  (BALB/c  mice)  and  homologous 
(A/J mice) systems to study the cross-reactive idiotypes among monoclonal antibodies 
to  PR8  and  B/Lee virus  HA and  the expression of these  idiotypes during  primary 
and secondary antiviral responses of BALB/c mice. Extensive idiotypic cross-reactivity 
was demonstrated among monoclonal antibodies specific for distinct antigenic deter- 
minants on PR8 hemagglutinin (HA). The study ofidiotypy of monoclonal antibodies 
against the same or overlapping antigenic determinants on B/Lee HA showed that 
these monoclonal antibodies  may bear (a)  a  true individual  idiotype not shared by 
other monoclonal antibodies, (b) idiotypes shared by few monoclonal antibodies, and 
(c)  true  cross-reactive  idiotypes  shared  by  all  of these  monoclonal  antibodies.  In 
contrast, no cross-reactive idiotypes were detectable among monoclonal antibodies to 
B/Lee HA and monoclonal antibodies to PR8 HA. Furthermore, we have shown that 
the anti-idiotype antibodies we used recognize determinants on monoclonal antibodies 
closely  associated  with  antigenic  binding  sites.  Finally,  studies  of  the  idiotypes 
expressed during primary and secondary antiviral HA responses of mice immunized 
with  B/Lee  virus  revealed  persistence  of some idiotypes  during  both  primary and 
secondary responses, whereas others were only expressed in the primary or secondary 
response. 
Received  for publication 13July  1981. 
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